InvestorsHub Logo
Followers 145
Posts 27550
Boards Moderated 3
Alias Born 02/07/2004

Re: midastouch017 post# 2822

Thursday, 02/18/2021 8:27:14 AM

Thursday, February 18, 2021 8:27:14 AM

Post# of 3866
RedHill Bio inks manufacturing deal for Movantik and RHB-204

Feb. 18, 2021 7:58 AM ETRedHill Biopharma Ltd. (RDHL)By: Mamta Mayani, SA News Editor

RedHill Biopharma (NASDAQ:RDHL) inks agreements with Cosmo Pharmaceuticals to manufacture two key products; Movantik, and RHB-204.

Movantik is prescribed oral peripherally acting mu-opioid receptor antagonist to treat opioid-induced constipation in adult patients with chronic non-cancer pain.

RHB-204 is a fixed-dose oral capsule for the treatment of nontuberculous mycobacteria disease.

RHB-204 has received FDA Fast Track, Orphan Drug and QIDP designations.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News